By Editor , 28 September 2026
MOYOM Biotech Lands Cathay Capital Funding for Global Expansion

Shanghai – – September 28, 2026 -- MOYOM Biotech, a Chinese developer of regenerative aesthetic biomaterials, has secured a new financing round from the Cathay Consumer Co-Creation Fund, managed by Cathay Capital, to fund international expansion of its flagship CaHA-based implant brand Aphranel®.

By Editor , 28 September 2026
Verisure Partners With Ting Labs to Bring Electrical Fire Prevention to Europe

Geneva – – September 28, 2026 -- Verisure has signed an exclusive partnership with US-based Ting Labs to commercialize an electrical fire prevention sensor across its European customer base, targeting a market where electrical faults cause 273,000 fires and €6.25 billion in property damage annually in the EU.

By Editor , 24 September 2026

Malmö – September 24, 2026 -- The EU's Empowering Consumers for the Green Transition Directive (EmpCo) takes effect September 27, 2026, requiring companies to substantiate any environmental claims made to consumers with clear, specific and credible evidence, a rule change welcomed by Duni Group.

By Editor , 24 September 2026
CRRC Completes 110-Meter Recyclable Blade With 95% Material Recovery

Hamburg, Germany – September 24, 2026 -- CRRC Corporation Limited (SHA: 601766) has completed production of a 110-meter recyclable wind turbine blade in Sheyang, Jiangsu Province, achieving a recovery rate exceeding 95% for key raw materials. The blade, developed in-house, targets commercial-scale recycling of ultra-large turbine blades as China's decommissioning volumes rise.

By Editor , 24 September 2026

Amsterdam – September 24, 2026 -- Morgan Stanley B.V. has published its interim report and financial statements for the six-month period ended June 30, 2026, in compliance with Article 5.25d of the Dutch Act on Financial Supervision (Wet op het financieel toezicht).

By Editor , 23 September 2026
Werfen Wins FDA Clearance, CE Mark for Aptiva APS IgA Assay

San Diego – September 23, 2026 -- Werfen has secured U.S. FDA 510(k) clearance and a CE Mark under the EU's IVDR for its Aptiva Antiphospholipid Syndrome (APS) IgA Reagent, completing a three-isotype APS testing portfolio on its Aptiva platform.

By Editor , 23 September 2026
Back Market Launches Coalition, Platform to Push 10-Year Smartphone Standard

Paris – September 23, 2026 -- A 200-gram smartphone requires more than 266 kilograms of raw material extraction, part of an annual global total exceeding 319 million tons of upstream materials pulled from the earth to manufacture smartphones alone, according to data cited by refurbished-tech marketplace Back Market.

By Editor , 23 September 2026
Unregulated Gambling Hits €91.6B, 72% of EU Online Market

Brussels – September 23, 2026 -- Unregulated online gambling operators generated an estimated €91.6 billion in gross gaming revenue (GGR) from EU 27 consumers in 2025, accounting for 72% of Europe's €128.0 billion online gambling marketplace, according to a new report from Gaming Compliance International (GCI) commissioned by the Campaign for Fairer Gambling (CFG).

By Editor , 21 September 2026
EU Approves NewAmsterdam-Menarini's Obicetrapib in Global First

Florence – September 21, 2026 -- The European Commission has granted marketing authorization for Ubeslo (obicetrapib 10 mg monotherapy) and Evlarco (obicetrapib 10 mg plus ezetimibe 10 mg fixed-dose combination), marking the first global regulatory approval of obicetrapib for NewAmsterdam Pharma (Nasdaq: NAMS) and partner Menarini Group.

By Editor , 20 September 2026
Xryma H1 Profit Collapses 99.8% as Banktech Group Completes T2 Build

Nicosia – September 19, 2026 -- Xryma Plc reported a 99.8% collapse in first-half profit to €0.03 million, down from €12.3 million a year earlier, as the Cyprus-based banktech group front-loaded spending on infrastructure ahead of a planned 2027 revenue ramp.